Histidine-Tryptophan-Ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death.

Abstract

Single-center studies have reported that liver allograft survival is not affected by preservation in histidine-tryptophan-ketoglutarate (HTK) versus University of Wisconsin (UW) solution. We analyzed the UNOS database of liver transplants performed from July, 2004, through February, 2008, to determine if preservation with HTK (n = 4755) versus UW (n = 12… (More)
DOI: 10.1111/j.1600-6143.2008.02478.x

Topics

Cite this paper

@article{Stewart2009HistidineTryptophanKetoglutarateI, title={Histidine-Tryptophan-Ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death.}, author={Zelda Stewart and Andrew M. Cameron and Andrew L. Singer and R. A. Montgomery and Dorry L Segev}, journal={American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons}, year={2009}, volume={9 2}, pages={286-93} }